title: GNAS gene mutation may be present only transiently during colorectal tumorigenesis.
abstract: Mutations of the gene GNAS have been shown to activate the adenylate cyclase gene and lead to constitutive cAMP signaling. Several preliminary reports have suggested a role for GNAS gene mutations during colorectal carcinogenesis, particularly mucinous carcinomas. The aim of this study was to clarify the incidence of GNAS mutations in adenomas (tubular, tubulovillous, and villous), carcinomas with residual adenoma, and carcinomas, and to relate these findings to mutations of the KRAS gene and to the mucinous status of the tumors. We used standard PCR techniques and direct gene sequencing to evaluate tumors for gene mutations. No GNAS mutations were identified in 25 tubular adenomas, but were present in 6.4% of tubulovillous adenomas and 11.2% of villous adenomas. A GNAS mutation was found in 9.7% of the benign portion of carcinoma with residual adenoma, but in none of 86 carcinomas. A similar trend was seen for KRAS mutation across the five groups of tumors. GNAS mutations may function as an important driver mutation during certain phases of colorectal carcinogenesis, but may then be lost once the biological advantage gained by the mutated gene is no longer necessary to sustain or advance tumor development.
authors.affiliation: Department of Medicine, Saint Barnabas Medical Center 100 Old Short Hills Road, Livingston, NJ 07039, USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Zauber
authors.affiliation: Department of Pathology, Saint Barnabas Medical Center 100 Old Short Hills Road, Livingston, NJ 07039, USA.
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Marotta
authors.affiliation: Department of Pathology, Saint Barnabas Medical Center 100 Old Short Hills Road, Livingston, NJ 07039, USA.
authors.forename: Marlene
authors.initials: M
authors.lastname: Sabbath-Solitare
keywords: GNAS gene mutations; colon adenomas; colon carcinogenesis; colon carcinoma; mucinous carcinomas